New clinical trials needed to evaluate the risks of testosterone treatment

by Dr. Enozia Vakil on  April 28, 2014 at 11:19 PM Research News
RSS Email Print This Page Comment
In order to evaluate the risks associated with the prescription of testosterone in older men, new clinical trials will be urgently required.
New clinical trials needed to evaluate the risks of testosterone treatment
New clinical trials needed to evaluate the risks of testosterone treatment

According to a Comment in The Lancet Diabetes and Endocrinology, written by Professor Stephanie Page, of the University of Washington and Harborview Medical Center, testosterone is now widely prescribed to older men, particularly in the USA which has brought an immediate need for appropriate clinical studies to assess the risks and benefits of testosterone treatment.

Existing studies have produced conflicting findings over whether the prescription of testosterone is associated with increased cardiovascular risk in older men, and ongoing studies are unlikely to adequately address this question, which has further increased the need for new clinical trials.

Source: ANI

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Clinical Trials Clinical Trials - The Past and The Future Clinical Trials - Different Phases of the trial Andropause / Male Menopause Adreno Cortical Carcinoma Is Your Man Moody? Placebo Effects: Rare Insights 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.


Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive